CYP3A4 and COVID-19: Accumulating evidences (Awortwe and Cascorbi, 2020; Ferron et al., 2020; Hodge et al., 2020) have showed that PK DDIs, primarily related to the presence of CYP3A4, might contribute to DILI in COVID-19 patients.